MediWound (MDWD) Scheduled to Post Earnings on Tuesday

MediWound (NASDAQ:MDWD) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, November 26th. Analysts expect MediWound to post earnings of ($0.48) per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

MediWound Stock Performance

Shares of NASDAQ MDWD opened at $16.48 on Monday. The stock has a fifty day moving average price of $17.21 and a two-hundred day moving average price of $17.39. MediWound has a 1 year low of $8.41 and a 1 year high of $24.00. The firm has a market cap of $177.82 million, a P/E ratio of -7.63 and a beta of 0.83.

Wall Street Analysts Forecast Growth

MDWD has been the subject of a number of research analyst reports. StockNews.com upgraded MediWound to a “sell” rating in a report on Monday, August 5th. HC Wainwright restated a “buy” rating and set a $28.00 price target on shares of MediWound in a report on Friday, October 11th.

MediWound Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.